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Abstract 
Obsessive-compulsive disorder (OCD) is a psychological disorder with debilitating impacts 
on many aspects of daily functioning, including relationships and quality of life. OCD is 
characterised by the presence of distressing, ongoing obsessional intrusions, and/or 
compulsions, which are extremely intrusive and time-consuming. There is accumulating 
evidence to suggest that higher-order thinking processes and beliefs (“metacognitions”) 
underlie many of the processes implicated in the formation and maintenance of OCD. 
Metacognitive models for OCD have been proposed, with debate as to whether such models 
are an expansion of CBT, or a separate entity. Metacognitive therapy (MCT) for OCD aims 
to modify the maladaptive metacognitive beliefs and processes implicated in the disorder, in 
order to alleviate symptoms. The current paper reports the outcomes of a preliminary trial, in 
which twenty-two adult outpatients with OCD received group MCT at the Anxiety Disorders 
Service in Canterbury (New Zealand). The results were promising, with significant decreases 
in OCD and depression symptoms, which were maintained at a three-month follow-up. The 
improvement in Yale-Brown Obsessive Compulsive Scale (Y-BOCS) scores between 
baseline and follow-up were large (d=1.3), comparable to the outcomes of well-established 
treatments. Similarly, as predicted, metacognitive beliefs were found to be correlated with 
OCD symptoms at baseline and follow up; and demonstrated large decreases from baseline to 
follow-up. Furthermore, this decrease in metacognitive beliefs throughout the study was 
significantly correlated with the decrease in OCD symptoms. These encouraging results add 
to the early empirical support for the efficacy of MCT as an OCD treatment approach, as well 
as reinforcing the role of metacognitions underlying this disorder. A large-scale, controlled 
trial is warranted, to enable firm conclusions about the efficacy of MCT and investigate the 
causal mechanisms of change. 
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Introduction 
Obsessive-Compulsive Disorder (OCD): Overview 
OCD is a psychological disorder characterised by the presence of repetitive, time-
consuming obsessions and/or compulsions, which cause significant impairment and distress 
to those with the disorder (American Psychiatric Association [APA], 2013). In addition to the 
obsessions and compulsions characterising the disorder, those with OCD often start to avoid 
situations which may trigger an obsession or a compulsion, compounding the impact of the 
disorder on many aspects of daily functioning (APA, 2013). Until recent changes in the 
classification of OCD in the DSM-5 (APA, 2013), in which it was given its own diagnostic 
category, OCD has been diagnosed and treated as an anxiety disorder for many decades and 
is still regarded as having a “close relationship” with anxiety disorders (APA, 2013).  
It is now accepted that OCD is not caused by the presence of obsessional intrusions per 
se; rather, it is the way these intrusions are mentally appraised that leads to, and maintains, 
OCD symptoms (Grøtte et al., 2015). In fact, numerous studies have shown that around 90% 
of the general population experience unwanted intrusions (e.g. Rachman & de Silva, 1978; 
Purdon & Clark, 1993), making them a ‘normal’ occurrence for most people. The content of 
intrusions is largely the same for those with and without the disorder, the difference lies in 
the frequency, distress, appraisal and response to the intrusion (Whittal & McLean, 1999). As 
will be discussed in the following sections, for those who develop OCD, the intrusions are 
misinterpreted; appraised as significant and harmful, which leads to the formation and 
maintenance of the cycle of OCD.  
Diagnostic features. Obsessions include intrusive thoughts, images, or impulses, which 
are experienced as inappropriate, unwanted and outside of the control of the person 
experiencing them (APA, 2013). The experience of unwanted intrusions in OCD is associated 
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with significant anxiety, and is often ‘neutralised’ or suppressed using an associated 
compulsive ritual. Common obsessions include those of contamination (such as from shaking 
hands or touching objects such as doorknobs), recurring doubts (such as whether they 
remembered to lock the front door, or if they might have run over someone in their car) or 
harmful impulses (such as to jump in front of a train, or to hurt a family member).  
Compulsions (or ‘rituals’) are repetitive, rigid acts that a person feels compelled to 
execute, in response to an obsession or internal ‘rules’ which must be followed (APA, 2013). 
Compulsions may take the form of overt behaviours, such as counting, washing or ordering, 
or ‘covert’ mental rituals, such as distraction, avoidance or the repetition of a calming 
thought. Compulsions are undertaken with the goal of reducing anxiety produced by an 
unwanted intrusion, or to prevent a feared event or situation from occurring; even though the 
compulsive behaviours may not be realistically linked to the event or situation they are 
intended to prevent or neutralise (APA, 2013). For example, an instance of a ‘magical 
thinking’ compulsion may be to avoid stepping on cracks to prevent loved ones from getting 
sick. However, even when compulsions are connected in a realistic way to the outcome they 
are intended to prevent (e.g. handwashing in response to fears of becoming contaminated) 
they are performed to an excessive extent, leading to impairment. 
Most people with OCD experience both obsessions and compulsions, as compulsive 
behaviours are often undertaken in response to unwanted obsessional intrusions, in order to 
alleviate the anxiety and distress caused by their presence (APA, 2013). Although it is 
possible to have either one in isolation and still meet the diagnostic criteria (APA, 2013), 
those presenting with only obsessions often partake in covert mental rituals which are not 
immediately evident, but are still present (Rees, 2009).  
A large-scale New Zealand mental health survey (NZMHS; Oakley Browne, Wells, & 
Scott, 2006) found that although OCD had a low prevalence rate compared to other anxiety 
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disorders (general population: 12-month prevalence = 0.6%, lifetime prevalence 1.2%), it had 
the highest interference with life (combining home, work/study, intimacy, and social life) of 
all anxiety disorders. It should be noted that the NZMHS (Oakley Browne et al., 2006) 
utilised a measure of OCD that has since been revised due to underestimating prevalence, so 
it is possible that mild cases were unable to be detected in this sample (J. Wells, 2006).  
In contrast to the pattern for other anxiety disorders, where reported prevalence rates are 
much higher for females than males, the NZMHS (Oakley Browne et al., 2006) found no 
significant sex difference in prevalence of OCD (lifetime prevalence: female = 1.4%, male = 
1.1%). Internationally, there is a pattern for females to have a slightly higher prevalence rate 
than males in adulthood, with the reverse gender pattern evident in childhood (APA, 2013). 
Fifty percent of those with the disorder reported an onset during childhood or adolescence 
(<18 years), with three-quarters reporting their OCD started by the age of 26 (Oakley Browne 
et al., 2006). Onset after the age of 35 is uncommon, although can occur (APA, 2013).  
If left untreated, OCD generally follows a chronic course, with the onset of symptoms 
typically being gradual (although acute onsets linked to a trigger are also possible) (APA, 
2013). The course of the disorder is often complicated by the presence of comorbid 
psychopathology, with only around 15% of those with OCD having no lifetime comorbidity 
(Clark, 2004). Around 76% of adults with OCD will also have a lifetime diagnosis of another 
anxiety disorder (such as panic disorder, generalised anxiety disorder, or social phobia), with 
around 63% having a lifetime diagnosis of a depressive or bipolar disorder (APA, 2013).  
Current Practice 
Despite theoretical and clinical progress in the field of anxiety disorders, OCD remains 
challenging to treat effectively (Rees & van Koesveld, 2008; Fisher, 2009). According to best 
practice guidelines for OCD treatment (APA, 2007) cognitive-behavioural therapy (CBT), 
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with exposure and response prevention (ERP) as a key component, is the recommended first-
line psychotherapeutic treatment for OCD, and may be combined with pharmacotherapy for 
more severe cases.  
Cognitive-behavioural therapy (CBT). CBT encompasses a broad “family of 
interventions” (Hofmann, Amundson, & Beck, 2013) which utilise both cognitive and 
behavioural techniques in the treatment of psychopathology. The application of CBT to the 
treatment of OCD began largely with the work of Salkovskis (1985) who proposed a 
cognitive-behavioural model of OCD. The model proposed that whilst intrusive thoughts 
were very common in the general population, the tendency to appraise these intrusions as 
dangerous or threatening leads to the formation, and subsequent maintenance, of OCD. The 
model has been refined by numerous theorists, mostly differing on the proposed primary 
faulty appraisal underlying the disorder; for example the need to control thoughts (Purdon & 
Clark, 1993), the overestimation of danger (van Oppen & Arntz, 1994), or an appraisal of 
personal significance (Rachman, 1993).  
To consolidate the cognitive understanding of OCD, the Obsessive-Compulsive 
Cognitions Working Group (OCCWG; 1997) assessed all the belief domains implicated in 
the disorder, and came up with six key cognitive OCD beliefs: inflated responsibility, over-
importance of thoughts, the importance of controlling one's thoughts, overestimation of 
threat, intolerance of uncertainty and perfectionism. Inflated responsibility refers to faulty 
appraisals about excessive personal responsibility, such that a person perceives themselves as 
responsible for preventing imagined harmful events (OCCWG, 1997). Over-importance of 
thoughts refers to the faulty appraisal that the mere presence of a thought signals that it is 
significant (OCCWG, 1997) and is linked to metacognitive ‘fusion beliefs’ (discussed 
below). Following from beliefs about responsibility and over-importance of thoughts, beliefs 
6 
 
about the importance of controlling thoughts posit that thoughts can and should be controlled, 
as they are significant, and can cause harm (OCCWG, 1997; Purdon & Clark, 1993). 
Overestimation of threat refers to the tendency to overestimate the likelihood and severity of 
harmful events occurring (OCCWG, 1997). Intolerance of uncertainty and perfectionism are 
related dysfunctional beliefs; referring to concerns about doing things perfectly, and 
eradicating any doubt or uncertainty about a situation, in order to prevent negative events 
from occurring (OCCWG, 1997; Woolcock, 2011). 
CBT focusses on challenging dysfunctional cognitive appraisals across these key belief 
domains, using various cognitive and behavioural techniques. These include identifying and 
assessing cognitive distortions (e.g. inflated responsibility), then reality-testing these 
distortions with techniques such as probability or responsibility pie charts (e.g. Rees, 2009). 
By definition, CBT includes a behavioural element, which is often ERP.  
Exposure and response prevention (ERP). ERP is a behavioural therapy technique 
developed by Meyer (1966), following the basic learning theory process of extinction of the 
OCD fear/anxiety response, via classical conditioning. It is commonly used as the 
behavioural component of CBT. The goal of ERP is to habituate anxiety: to expose a client to 
a feared stimulus (in this case, a distressing obsession) and prevent the client in engaging in 
the coping methods (i.e. compulsions) usually utilised to reduce the anxiety invoked by the 
intrusion. In this way, clients learn that anxiety naturally abates over time, even when they do 
not engage in their coping rituals. Before embarking upon ERP, the client and therapist must 
work out a detailed ‘fear hierarchy’ in which the client works up to the most anxiety-
producing situation through moving through a number of gradually-increasing steps.  
Efficacy. CBT is undoubtedly efficacious, with decades of research supporting its use in 
the treatment of OCD. Treatments with an exposure component (mainly ERP) are supported 
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by the largest evidence base (Foa, 2010), and may be delivered as a component of CBT, or as 
a stand-alone treatment. The superior efficacy of ERP as a treatment technique depends on it 
being delivered in a consistent, optimal manner (Fisher & Wells, 2005b; Foa, 2010). This is 
less likely to be the case outside of rigorous research studies: a survey of psychotherapists 
found that less than half of those interviewed felt experienced enough or well-trained to use 
ERP themselves, despite its effectiveness (Kulz et al., 2009). 
A meta-analysis, investigating the current efficacy of OCD psychotherapy, compared 
CBT, ERP alone, and cognitive therapy (without a behavioural element) (Eddy, Dutra, 
Bradley, & Westen, 2004). Of all treatment completers, only two-thirds responded with 
symptomatic improvement (Eddy et al., 2004). Intention-to-treat analyses, taking into account 
attrition, found that only half of all patients receiving current OCD psychotherapies improve 
(Eddy et al., 2004). Furthermore, the mean Y-BOCS score at post-treatment was 12.70 
(SD=2.29), which represents a substantial decrease from baseline, but does not reach sub-
clinical levels of symptoms (Eddy et al., 2004). Another meta-analysis of exposure-based 
CBT reported an average pre-post OCD symptom reduction of 48% across 17 controlled 
studies (Abramowitz, Franklin, & Foa, 2002). However, these figures obscure several 
limitations: the majority of those treated with ERP remain symptomatic after treatment; its 
aversive nature leads to high refusal and attrition rates (around 20%, Foa, 2010); and there is 
a large minority of completers (also around 20%; Foa, 2010) who are non-responsive (see 
Fisher, 2009; Foa, 2010 for reviews).  
A Metacognitive Approach  
Metacognition, or “thinking about thinking” (Flavell, 1979) is gaining increasing interest 
in the field of OCD research and practice (Rees & Anderson, 2013; Wells, 2013). 
Metacognitive approaches to OCD emphasise the significance of maladaptive, higher-order 
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thinking processes and beliefs (“metacognitions”) in the formation and exacerbation of OCD.   
Models of metacognition. The first, explicitly metacognitive model of OCD, is that of 
Wells (2000; and Matthews, 1994), whose Self-Regulatory Executive Function (S-REF) 
model ascribes a metacognitive basis to all emotional dysfunction. Wells developed, adapted 
and coined a number of key terms and techniques used in MCT (e.g. ‘detached mindfulness’) 
and developed a prototype MCT treatment model for a number of disorders, including OCD 
(2000).  
The S-REF model is based around the existence a perseverative thinking style, the 
‘cognitive attentional syndrome’ (CAS; Wells & Matthews, 1994) which underlies emotional 
disorders, and consists of worry and rumination, maladaptive attentional style and 
counterproductive methods of coping. Applied to OCD (Wells, 1997; 2009), this model 
emphasizes the role of three types of metacognitive thoughts, which are implicated in the 
formation and maintenance of the disorder: thought-fusion beliefs, positive beliefs about 
rituals, and ‘stop’ criteria which signal a ritual can be ended. Wells (1997) adapted 
Rachman’s (1993) concept of ‘thought-action fusion’, originally conceived as a cognitive 
bias, into ‘thought-fusion beliefs’; a metacognitive construct comprised of thought-action 
fusion (the belief that a thought can provoke action), thought-event fusion (the belief that 
thoughts can cause events to happen) and thought-object fusion (beliefs that thoughts can be 
passed into objects). In this model, the activation of thought-fusion beliefs precedes 
appraisals of intrusions: for example, a thought of harming a loved one is appraised as very 
significant and dangerous only if one holds the faulty metacognitive belief that thinking 
something can make it happen (Solem, Myers, Fisher, Vogel, & Wells, 2010).  
Another approach to metacognition is that of Clark (2004), whose appraisal model, and 
treatment manual influenced the current study. Clark has proposed a key role for 
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metacognitions in OCD from early on (e.g. Clark & Purdon, 1993; Purdon & Clark, 1999) 
advocating for their inclusion in the six main underlying OCD beliefs discussed above 
(OCCWG, 1997). Clark’s model of OCD (2004) upon which the current treatment manual 
was partly based, is not an explicitly metacognitive model, rather uses the language of 
‘appraisals’. However, examination of Clark’s model, as well as his treatment plan, reveals a 
key role for faulty metacognitive beliefs.  
Clark’s model (2004, p.90; Figure 1) suggests that a trigger causes an obsessional intrusion to 
occur, which (in those with OCD) activates a metacognitive appraisal of the intrusion as 
significant and dangerous. Once this appraisal has occurred (i.e. metacognitive beliefs are 
activated) a compulsive ritual is undertaken, in order to attempt to control or neutralise the 
intrusion. In the short term, ‘getting rid of’ the intrusion decreases anxiety, and increases 
feelings of perceived control over obsessional intrusions. In the long term, however, the 
faulty appraisals of intrusions, combined with the attempts to control them, have the effect of 
increasing the salience and frequency of the intrusions. This increased frequency of intrusions 
is subsequently appraised as a failure of control, which increases anxiety, and sparks 
heightened compulsive control strategies. Thus the anxiety-producing cycle of intrusions and 
compulsions is perpetuated and exacerbated. Metacognitive beliefs about the control and 
importance of thoughts feature prominently in this model, and must be modified in order for 
patients to ‘let go’ of their obsessions (Clark, 2004). 
Clark (2004) asserts that the modification of metacognitive beliefs (especially those 
regarding control of thoughts) is an essential component of an effective CBT programme, and 
must be addressed alongside faulty cognitions. He discusses “recurring cognitive themes” 
(Clark, 2004), which are made up of cognitive and metacognitive beliefs, and underlie the 
faulty appraisals at the core of the disorder. As illustrated by Clark, these “themes” (Clark,  
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Figure 1. Appraisal Model of OCD, adapted from Clark (2004, p.90). Permission for 
use in this document obtained from David Clark.  
 
2004, p.261) largely align with the six core OCD beliefs posited by the OCCWG (1997). 
Differing from a traditional CBT perspective, Clark recommends rising above the 
idiosyncratic content of these faulty beliefs to identify and challenge the recurring, 
overarching themes of the disorder, allowing the client to let go of the obsession. He also 
suggests that CBT which targets interventions at both levels of appraisal, instead of a 
narrower focus on cognitive dysfunction, will have the best therapeutic outcomes. In this 
way, Clark’s treatment model is consistent with a “soft” approach to MCT (discussed below), 
even though he describes it as CBT; supporting an overlap between the approaches.  
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Metacognitions: A separate approach or extension of the existing field? Despite the 
overlap between approaches mentioned above, there is not yet consensus as to whether the 
metacognitive approach is an extension of the current cognitive-behavioural field, or a 
separate entity (Rees & Anderson, 2013; Dobson, 2013). Although Wells is explicit in calling 
his approach (1997; 2000; 2009) a ‘metacognitive theory’, there have been aspects of 
metacognition in cognitive-behavioural models of OCD for a number of years (e.g. 
Salkovskis, 1985; Purdon & Clark, 1993; Emmelkamp & Aardema, 1999). In fact, the 
appraisal of intrusive thoughts which underlies the disorder is an inherently metacognitive 
process (Rees & Anderson, 2013). As mentioned above, a core role for metacognitive beliefs 
and processes in OCD was recognised at the at the cognitive working group conference 
(OCCWG, 1997), which spawned several measures of metacognitive beliefs (such as the 
OBQ-44), and is reflected in the inclusion of metacognitions in the key six OCD ‘cognitive’ 
belief domains agreed upon by these theorists.  
It has been suggested (e.g. Fisher, 2009; Solem et al., 2010) that dysfunctional cognitive 
beliefs do not need to be addressed in the treatment of OCD, as they are a by-product of 
faulty metacognitive beliefs. Such arguments do not deny the role of dysfunctional cognitive-
level beliefs in OCD, nor the importance of modifying them, but argue that eliciting 
metacognitive-level change will have a sufficient flow-on effect on these dysfunctional 
cognitive beliefs. However, Wells (2009) has differentiated between “hard” and “soft” forms 
of metacognitive theory, the former in which a focus on modifying faulty metacognitions 
should replace the modification of dysfunctional cognitions (which is consistent with the 
argument of Fisher, 2009, above). Conversely, in his discussion of a “soft” form of the 
theory, Wells (2009) proposes metacognitions may also exist alongside cognitive 
dysfunctional beliefs. Thus treatment may “retain a component of challenging traditional 
beliefs” (Wells, 2009, p. ix) as long as co-existing metacognitions are also dealt with, which 
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is consistent with the treatment model of Clark (2004). The current study follows this latter 
metacognitive perspective, delivering a more comprehensive treatment by addressing both 
faulty metacognitions, as well as dysfunctional cognitions which play a well-documented role 
in OCD.   
Metacognitive therapy (MCT). Based on the key role of faulty metacognitions in 
OCD, MCT focusses on challenging the relationship clients have with their thoughts, 
impulses and beliefs, rather than challenging the specific content (as is the case in standard 
cognitive therapy). Therefore when the validity of thoughts are tested in treatment, 
metacognitive thoughts are the target (e.g. “thinking something means that it is true”). This 
allows clinicians to bypass the time-consuming process of cataloguing and challenging each 
specific obsession or compulsion, as well as making it applicable across OCD subtypes and 
presentations (Fisher, 2009; Rees & van Koesveld, 2008). As described by Rees (2009), the 
metacognitive approach reshapes clients’ relationships with their thoughts, focussing on the 
idea that “thoughts are not facts, and therefore do not need to be engaged with” (p.108). MCT 
can thus be seen as more acceptance-based than change-focussed (Rees & Anderson, 2013), 
the goal of treatment not being to eliminate symptoms (including intrusive thoughts) per se, 
but to accept their occurrence and change the way they are experienced (Rees, 2009). 
To achieve this, MCT utilises psychoeducation to normalise the experience of intrusions, 
Socratic dialogue to keep people in a metacognitive mode of processing, and skills and 
techniques such as ‘detached mindfulness’ and behavioural experiments (Fisher & Wells, 
2005a) to alter maladaptive metacognitive beliefs about the disorder.  
 Key strategies of MCT. 
Detached mindfulness (DM). DM, conceptualised by Wells (2000; and Matthews, 1994), 
is a state of meta-awareness, in which clients relate to their thoughts in an objective, detached 
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way. DM is central to metacognitive theory, as it facilitates the key goal of being conscious 
of thoughts, but not engaging with them or giving them undue attention, because of the 
understanding that thoughts are not facts, but just mental activity (Wells, 2005). 
Subsequently, when operating in a DM manner, there are no attempts to control, suppress or 
engage in behaviours in response to thoughts (Wells, 2005). The goal in MCT is to teach DM 
to patients using neutral thoughts to begin with, slowly getting them to utilise it for their 
OCD cognitions.  
There are a number of techniques which aim to increase DM, including free association 
tasks, suppression counter-suppression tasks and the ‘attention training technique’ (ATT; 
Wells, 1990; 2000; 2009), which was used in the current study. ATT, introduced by Wells 
(1990), assists in the facilitation of DM by interrupting perseverative self-focussed attention, 
expanding cognitive flexibility and allowing participants to practice not engaging with the 
inner “noise” of intrusions (Wells, 2009). ATT is taught in an auditory manner, requiring 
participants to engage in selective attention, attentional switching and dividing attention 
between various external sounds. The procedure takes about 10-15 minutes, and is designed 
to be demanding on attentional resources (similar to the effect of intrusions), so that clients 
learn flexibility and attentional control in a context that is non-threatening, and non-self-
referent (Wells, 2000). This skill – increased metacognitive control over the allocation of 
attention – allows attention to be less “bound” to intrusions when they occur (i.e. ‘detached 
mindfulness’), and leaves more processing capacity available for the modification of faulty 
metacognitions (Wells, 2000).  
DM is utilised to promote and facilitate metacognitive change within a treatment 
programme: it is not used as a coping method, and needs to be carefully delivered so that 
clients do not use DM as a means to regulate their emotions or neutralise perceived threats 
(Wells, 2005). Instructions are given during the task that the aim of ATT is not to suppress or 
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escape thoughts, but to practice focusing attention (Wells, 2005); instructions also advise that 
if an intrusion occurs, to not react or engage with it, but rather to refocus attention to the 
sounds, as per instructions. From an S-REF model perspective, DM can be seen as the direct 
opposite to the CAS – in which thoughts are fixated and ruminated upon, attention is 
focussed and used to monitor for threats, and maladaptive methods of coping are activated in 
response to intrusive thoughts (Wells, 2005). Similarly, in regards to Clark’s model, DM and 
ATT can be conceptualised as a way of disrupting the OCD cycle, by improving the ability to 
detach attention from intrusions, and allowing for the modification of the faulty 
metacognitive appraisals of these intrusions.   
Behavioural experiments. While not specific to MCT (see, for example, Whittal & 
McLean, 1999 for a discussion of the use of behavioural experiments in CBT), behavioural 
experiments are one of the key exposure techniques used in MCT, instead of prolonged ERP 
exposure procedures (Fisher & Wells, 2008; Wells, 2009; Fisher, 2009). The key difference 
between exposure from an MCT perspective and an ERP perspective is the goal of the 
exposure. As explained earlier, the goal of ERP is to habituate the client to anxiety, through 
preventing the completion of a mental or behavioural ritual. The reduction in anxiety required 
for the ERP to be effective can take around 60-90 minutes (Fisher & Wells, 2005a) which is 
part of the reason it is so aversive. In contrast, exposure under a metacognitive rationale is 
brief (5 minutes), and is designed explicitly to challenge and disconfirm faulty metacognitive 
beliefs. This is because from a metacognitive perspective, it is faulty metacognitive beliefs 
that maintain the disorder, and lead to distress (Fisher, 2009). As such, the modification of 
these beliefs will result in reduced anxiety, thus clients do not have to struggle through 
lengthy ERP procedures to habituate their anxiety behaviourally (Fisher & Wells, 2005a). 
Response prevention in MCT behavioural experiments thus serves to allow new 
metacognitive knowledge to develop, as clients learn that it is their faulty metacognitive 
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beliefs and subsequent appraisals of intrusions at the root of the disorder, and that performing 
their rituals is not stopping feared obsessional outcomes, but rather reinforcing them (Fisher 
& Wells, 2005a; Fisher, 2009). 
As both ERP and behavioural experiments are exposure-based behavioural techniques, 
the distinction between them is not always be obvious. An example from the current study - 
worry postponement - demonstrates the key difference. In the current study, the concept of 
“worry postponement” is utilised to build on DM skills, as well as challenge dysfunctional 
beliefs about the uncontrollability of worry, and the belief that worrying thoughts should be 
engaged with. Participants are asked to ‘postpone’ their worry, by registering a worrying 
thought, then detaching from it, telling themselves that they will come back to this thought 
later. A small amount of time is set aside once a day to deal with worried thoughts, if 
participants still feel the need to address them. This behavioural exercise tests metacognitive 
beliefs about worry, utilising DM to temporarily postpone worry, rather than requiring 
participants to sit with their worry or anxiety and wait for it to abate. In this way, there is a 
clear distinction in the rationale of behavioural experiments in MCT-based therapy, and ERP 
used in CBT.   
  Empirical support for the role of metacognitions in OCD. There are a growing 
number of studies supporting the role of metacognition in the development and persistence of 
OCD symptoms (see Rees & Anderson, 2013 for a review). A range of metacognitive beliefs, 
such as thought-fusion beliefs, and beliefs about the perceived danger of thoughts, have been 
found to be significantly correlated with OCD symptoms and their improvement. The 
metacognitive belief about the over-importance of thoughts was first linked to obsessional 
rumination in a clinical population, in which the majority of the patients (84%) endorsed the 
statement “thinking about something means it is true” (Freeston, Ladouceur, Letarte & 
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Rheaume, 1994). Prospective studies with non-clinical samples have demonstrated that 
metacognitions, such as thought-fusion beliefs and beliefs about the significance of thoughts, 
have a causal role in the aetiology of OCD (Myers, Fisher & Wells, 2009; Myers & Wells, 
2013). 
There is evidence that behavioural techniques delivered in MCT can be more effective 
than the currently-recommended behavioural technique of ERP. In a test of the metacognitive 
model, Fisher and Wells (2005a) compared ERP with brief metacognitively-delivered 
behavioural experiments, finding that the behavioural experiments were more effective than 
ERP in reducing anxiety, thought-fusion beliefs and the desire to neutralise intrusions. 
Similarly, Solem, Håland, Vogel, Hansen and Wells (2009) found that the therapeutic 
benefits demonstrated by ERP were actually explained and predicted by changes in 
metacognitive beliefs. 
Furthermore, there is increasing evidence that improvement of OCD symptoms is better 
explained by underlying metacognitive processes than factors from other dominant theories. 
Regression analyses from a clinical study (Solem et al., 2009) showed that change in 
metacognitions not only accounted for a large portion (22%) of the variance in post-treatment 
symptoms, but also that metacognitions emerged as the only independent predictor of 
symptomatic change, over and above cognitive factors (responsibility and perfectionism). 
Similarly, meta-cognitive thoughts have been shown to mediate the relationship between 
responsibility appraisals and symptoms (Gwilliam, Wells, & Cartwright-Hatton, 2004).  
Application of metacognitive therapies to OCD. Despite the growing theoretical and 
empirical support for metacognitive theory, described above, the practical application of 
metacognitive therapy to the treatment of OCD is still in preliminary stages, with only a small 
handful of studies.  
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There has only been one previous group MCT treatment for OCD (Rees & van Koesveld, 
2008). Their study (N=8) followed a treatment manual (Rees & van Koesveld, 2006) based 
on Wells’ (2000) MCT treatment model for OCD. There were 12, 2-hour group sessions, and 
then a follow-up at 3-months. The group attained encouraging results: at follow-up, the 
average improvement on the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) was 61%.  
A case series test of MCT conducted by Fisher and Wells (2008) also supports MCT’s 
efficacy in the treatment of OCD. After a 3-4 week no-treatment period to establish a stable 
baseline, the participants attended 12-14 individual one-hour MCT sessions, with a 3 and 6-
month follow up. All four of the participants demonstrating large treatment gains, with an 
average improvement of 70% on the Y-BOCS.  
Shareh, Gharraee, Atef-Fahid and Eftekhar (2010) conducted a small (N=19 completers) 
study comparing individual MCT, fluvoxamine or a combined MCT/fluvoxamine condition. 
Their MCT protocol was drawn from Wells (2009), which is in turn, based on the prototype 
model of MCT for OCD in Wells (2000). After 10 weekly sessions, the MCT condition 
demonstrated large treatment gains, with a 76% drop in Y-BOCS scores, which was 
significantly more successful than the fluvoxamine treatment.  
A limitation of both Fisher and Wells (2008) and Rees and van Koesveld (2008) studies 
was that the primary outcome measure, the Y-BOCS, was administered by the same 
clinicians running the group treatment, which has the potential to artificially inflate the level 
of improvement by eliciting socially-desirable responding from the participants. This is 
potentially also the case for Shareh et al. (2010) who do not state who administered the Y-
BOCS in their study. For Fisher & Wells (2008) this limitation is mitigated somewhat by also 
having participants complete self-report measures, which showed a similar pattern of results 
to the clinician-administered tests. The current study utilised self-report measures, not 
administered by the clinicians running the groups, which may reduce bias. However, the 
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clinicians were present while the measures were completed, the effect of this on participant 
responses is unable to be determined, as there appears to be no literature addressing this 
situation.  
Fisher and Wells (2008) and Shareh et al. (2010) also employed relatively strict inclusion 
criteria, which further limits the generalisability of their findings. In addition to a primary 
diagnosis of OCD, some of Fisher and Wells (2008) required participants: to be experiencing 
both obsessions and compulsions; to have had OCD for over a year; to not be receiving any 
psychological treatment concurrently; to not have received cognitive or behavioural 
treatments in the past two years; show no sign of psychosis or medical condition underlying 
the anxiety; and be either taking no medication, or be taking medication that has been stable 
for three months. Shareh et al. (2010) had similar criteria, also excluding those with any other 
comorbid Axis-I disorders, personality disorders or substance abuse disorders; limiting the 
sample to between the ages of 18 and 50; and excluding anyone who had received 
psychological or pharmaceutical treatments in the past month. 
Other iterations of MCT are not as comparable to the current study, but also provide 
support for the clinical utility of MCT for OCD. A randomised controlled trial (RCT), 
comparing individual MCT and ERP for children and adolescents with OCD, found that 
MCT was also highly effective in that population (Simons, Schneider, & Herpertz-Dahlmann, 
2006). The study utilised techniques by Salkovskis (1999) and Wells (1997, 2000), adapted 
for use with children and adolescents, as well as an adapted version of the Y-BOCS (CY-
BOCS; Scahill et al., 1997), and found that MCT was highly effective, even though it was 
delivered in fewer sessions than the ERP condition (9 compared to 13; Simons et al., 2006). 
At post-treatment, the MCT condition had improved by 75%, and the ERP condition by 
89.7%; although the participants in the MCT condition had significantly higher CY-BOCS 
scores than the ERP condition at baseline. The ‘MCT’ condition blended CBT and MCT 
19 
 
techniques, taking a “soft” metacognitive approach (Wells, 2009); supporting the perspective 
that combining MCT and CBT techniques can be effective in the treatment of OCD.  
Other applications of MCT have been a preliminary study via videoconference (N=3; Fitt 
& Rees, 2012) and an electronic self-help programme, ‘MyMCT’ (N=86; Moritz, Jelinek, 
Hauschildt, & Naber, 2010) which incorporated a range of cognitive and metacognitive 
elements. Both of these studies achieved significant reduction in OCD symptoms, as 
measured by the Y-BOCS, but will not be discussed due to the key methodological 
differences between them and the current study.   
Group Therapy 
There are several advantages to delivering OCD treatment in a group format; including 
beneficial therapeutic factors, and cost-effectiveness in utilising a limited amount of skilled 
therapists in an efficient manner (Himle, van Etten, & Fischer, 2003).The dynamics of a 
cohesive group helps to foster peer support, encouragement and modelling from the other 
members, as well as to normalise and destigmatise OCD symptoms - a crucial foundation of 
the MCT approach (Rees & van Koesveld, 2008). A highly cohesive group is linked to higher 
attendance, empathy and self-reflection, all of which contribute to treatment success (Yalom 
& Leszcz, 2005). In a self-reinforcing loop, treatment success then further increases the 
engagement, intimacy, and disclosure of the group (Yalom & Leszcz, 2005). Rees (2009) 
suggests that realising they are not alone in their OCD experience is one of the most powerful 
influences of being in a group setting for participants, helping to counter feelings of shame 
and being ‘different’. Furthermore, working alongside others who face similar challenges, 
and seeing them improve can instil hope in other group members (Yalom & Leszcz, 2005), as 
well as allow members to detach from their own OCD experience, and take a more objective 
stance towards the treatment. 
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From a practical perspective, delivering treatment to a group also has the benefit of time-
efficiency. Treating several clients at a time not only means clients may have a shorter wait-
time before receiving treatment, but it also means that the overall contact hours per client is 
significantly reduced (Himle et al., 2003). This also translates into cost savings, as time-
intensive treatment is delivered to multiple clients at one time. 
Despite the many benefits of group psychotherapy, there are also some challenges. Just 
as the therapeutic relationship is the foundation of success in individual therapy, group 
cohesiveness is essential for other therapeutic factors to be effective (Yalom & Leszcz, 
2005). Even the most skilled psychotherapist will experience client dropout, but the loss of 
members in a group setting can be particularly harmful to the group milieu and cohesion 
(Yalom & Leszcz, 2005). In the current study, three of the participants who dropped out were 
from the same group; although it cannot be confirmed, it is possible that these dropouts 
influenced group cohesion, and further drop outs. Another risk of group treatment is that 
individual members might not receive adequate attention from the therapist (Whittal & 
McLean, 1999), although this might be more of an issue in therapeutic modalities with highly 
individualised content (i.e. CBT, or ERP), rather than MCT, which has been suggested to be 
conducive to delivery in a group format (Rees & van Koesveld, 2008).  
It has been suggested that a well-matched group is key to treatment success (Yalom & 
Leszcz, 2005). Clinical observations suggest that a group that has a member (or members) 
with higher severity than the rest can have mixed results (Whittal & McLean, 1999). Less-
severe group members may be motivated to not become like the more severe member, and 
thus work harder in therapy, but it can also cause them anxiety (Whittal & McLean, 1999). 
Similarly, the higher-severity client may become discouraged that they are not ‘keeping up’ 
with the improvement of the other members of the group. In this situation, encouraging 
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clients to compare their treatment progress only to themselves (rather than to other group 
members) is important (Whittal & McLean, 1999).  
There is not yet any research comparing group and individual MCT treatment, due to the 
emerging nature of the field. However, there is increasing evidence of the excellent 
performance of other group-based therapies for OCD (Anderson & Rees, 2007; Jónsson & 
Hougard, 2009). A systematic review and meta-analysis of group OCD treatment (CBT with 
or without ERP) (Jónsson & Hougaard, 2009) found an average pre-post treatment effect size 
of 1.18 across 13 eligible studies. All of these studies utilised the Y-BOCS (either clinically-
rated or self-report version), with an average pre-post decrease of 7.5 points. The authors 
concluded that more research into the efficacy of group therapy, vis-à-vis individual therapy 
is needed, however that group-based treatment is certainly effective. A later study by the 
same authors (Jónsson, Hougaard, & Bennedsen, 2011) found that, although the pre-post 
effect sizes seemed larger for individual treatment, the difference was not statistically 
significant, which is in line with previous findings (e.g. Anderson & Rees, 2007). 
The Current Research 
The aim of the current study was to implement a new treatment protocol of MCT for 
OCD, and support the efficacy of using MCT to treat groups of clients with OCD using new 
cohorts of participants. The current study took a metacognitive approach combining models 
and treatment protocols of Clark (2004) and Wells (2009). The study, in a naturalistic 
outpatient clinical service for adults, aimed to replicate the findings of Rees and van 
Koesveld (2008); adding to the fledgling research in this area, as well as enhancing OCD 
treatment services in Christchurch. This study extends Rees & van Koesveld’s (2008) study 
by going beyond pre-post treatment analyses and looking at the relationship between 
metacognitive belief change and symptom change. The current study also builds on the 
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current literature by delivering the same treatment manual to several cohorts, with different 
therapists conducting the groups, thereby increasing the generalisability of the findings. 
The main hypotheses of the current study were: 
- As found by Rees and van Koesveld (2008), OCD symptoms and depressive 
symptoms will decrease significantly from baseline to post-treatment and follow-up. 
- Metacognitive beliefs will also decrease significantly from baseline to post-treatment 
and follow-up. 
- Metacognitive beliefs will be positively correlated with OCD severity at baseline and 
follow-up.  
- Change in metacognitive beliefs will be significantly correlated with change in OCD 
symptoms. 
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Method 
Design 
This study was an open trial of group metacognitive therapy for adult outpatients with 
OCD. Participants were assessed at multiple time points: pre-treatment, during treatment and 
at three monthly follow-up sessions. Ethical approval was granted by the Upper South 
Regional Ethics Committee (Appendix A), and all participants were supplied with a detailed 
description of the study (Appendix A), before giving their signed, informed consent 
(Appendix B). 
Participants 
Five groups of adults with a primary diagnosis of OCD were consecutively recruited 
between 2011 and 2014, as part of an ongoing OCD group treatment study at the Anxiety 
Disorders Service, a referral-based outpatient service of the Canterbury District Health Board 
(New Zealand). Participants were assessed to ensure their suitability for group treatment, 
before being invited to join the treatment group. Participants were not excluded if they were 
taking prescribed psychoactive medication. Exclusion criteria were: the presence of a 
significant substance use disorder; posing a significant risk of harm to self or others; and the 
presence of a significant cognitive impairment. Twenty-seven participants were accepted into 
the treatment programme, with 22 completing the programme; one withdrawing before the 
study and four participants withdrawing during the study. Each group consisted of between 
two and six participants (completers).  
Measures  
At baseline, clinicians saw each participant separately for two hours, completing a 
detailed diagnostic and behavioural analysis. Self-report information about demographics 
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(age, gender, ethnicity, education, occupation, relationship status and medications) was 
collected at baseline and the following self-report measures were completed at baseline, 
during treatment and at follow up: 
Obsessive-compulsive symptoms. 
Yale-Brown Obsessive Compulsive Scale (Y-BOCS; Self-report version; Baer, 2000). 
The Yale-Brown Obsessive-Compulsive Scale, Self-Report is a participant-completed 
version of the “gold standard” (Antony, 2001) Y-BOCS (Goodman et al., 1989), a clinician-
rated measure of OCD symptoms, severity and treatment response.  
This study utilised the 10-item severity scale portion of the Y-BOCS, with each item 
being rated on a 5-point scale from 0-4. Five questions pertain to obsessions, and five to 
compulsions, with clients asked to answer based on their experience in the past seven days. 
Questions are general, not focussing on particular subtypes of OCD, rather measuring degree 
of impairment with questions relating to distress, interference and frequency of symptoms. 
Total scores range between 0 and 40, with a higher score reflecting higher OCD severity. 
Severity rating cut-off scores are as follows: 0-7=sub-clinical, 8-15=mild, 16-23=moderate, 
24-32=severe and 33-40=extreme. 
 The self-report version has demonstrated strong convergent validity with the clinician-
administered version, as well as superior internal consistency and one week test-retest 
reliability (α=.82-.88; Steketee, Frost, & Bogart, 1996). There is good correlation with other 
measures of OCD for both the subscales and Y-BOCS total score (Antony, 2001). It has been 
suggested that the Y-BOCS has poor discriminant validity, due to high correlations with 
scales measuring anxiety and depression (Goodman et al., 1989; Antony, 2001). However, it 
is sensitive to change following treatment, and has thus become the scale of choice for 
measuring improvement in OCD symptoms in treatment studies (Antony, 2001). 
25 
 
Padua Inventory–Washington State University Revision (PI-WSUR; Burns, Keortge, 
Formea, & Sternberger, 1996). The Padua Inventory – Washington State University 
Revision (PI-WSUR) is a 39-item, self-report scale of obsessions and compulsions, 
consisting of five subscales: ‘Obsessional thoughts to harm self/others’, ‘Obsessional 
impulses to harm self/others’, ‘Contamination obsessions and washing compulsions’, 
‘Checking compulsions’ and ‘Dressing/grooming compulsions’. Clients answer each question 
on a 5-point scale based on the level of disruption or impairment caused by each particular 
thought or behaviour (from 0 = “not at all” to 4 = “very much”). The total score – a sum of all 
39 items – can range from 0 to 156. Burns et al. (1996) reported a mean score of 54.93 (SD = 
16.72) for an OCD sample. 
The PI-WSUR total score has been shown to have excellent internal consistency (α = 
.92), with the subscales ranging from fair (α = .77 for ‘obsessional thoughts to harm 
self/others’) to good (α = .88 for ‘checking compulsions’) for a normative sample (Burns et 
al., 1996). Test-retest reliability for the total PI-WSUR score on the same sample was .76, 
with correlations ranging from .61 (‘obsessional thoughts to harm self/others’) to .84 
(‘obsessional impulses to harm self/others’) for the subscales (Burns et al., 1996). 
The PI-WSUR has better psychometric properties than the original Padua Inventory (PI; 
Sanavio, 1988), including being better at discriminating OCD symptoms from worry than its 
predecessor; sharing only 12% of its variance with the Penn State Worry Questionnaire 
(Meyer, Miller, Metzger & Borkovec, 1990), compared to 34% for the PI (Burns et al., 1996). 
Obsessive-Compulsive Disorder Scale (OCD-S, Wells, 2009). The OCD-S is a four-
item, self-report scale, included to supplement existing assessment measures. The items 
measure the level of distress caused by obsessions, the frequency of OCD coping behaviours 
and avoidance behaviours, and degree of agreement with a number of metacognitive belief 
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statements. The scale is designed to be used weekly, as a measure of metacognitive-relevant 
response to treatment.  
The first item measures how distressing and disabling obsessional thoughts or urges have 
been in the past week, on a 9-point scale (from 0 = “not at all”, to 8 = “extremely, the worst 
they have ever been”). The second item requires frequency ratings for nine different 
behaviours used to cope with obsessions in the past week (from 0 = “none of the time” to 8 = 
“all of the time”), including behaviours such as checking, thought-control and reassurance-
seeking. Using the same rating scale, the third item measures the frequency of six avoidance 
behaviours in the past week, including avoidance of certain thoughts, social situations or 
uncertainty. The final item in the scale measures degree of agreement with 10 different 
metacognitive beliefs about obsessions and rituals (from 0 = “I do not believe this at all”, to 
100 = “I’m completely convinced this is true”). Examples of these metacognitive 
beliefs/statements are “obsessional thoughts could change me as a person”, “some thoughts 
must always be controlled” and “something bad will happen if I don’t perform my rituals”. 
In this study, the score for each item was calculated, creating subscales scores for 
‘distress’, ‘coping’, ‘avoidance’ and ‘beliefs’. A summed total score was not used. There are 
no validation data available for this scale. 
Depressive symptoms. 
The Beck Depression Inventory-II (BDI-II; Beck, Steer, & Brown, 1996). The BDI-II 
is a 21-item, self-administered survey of depressive symptoms experienced over the past two 
weeks. The items are summed to give a single total score, with a higher score indicating 
greater severity of depressive symptoms. Each item is answered on a 4-point scale (0-3), with 
the exception of two items (items 16 and 18) which are answered on a 7-point scale, to reflect 
a decrease or increase in sleep and appetite. The cut-offs for severity categories are as 
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follows: “minimal” = 0-13, “mild” = 14-19, “moderate: = 20-28, “severe” = 29-63 (Beck, 
Steer, & Brown, 1996). The BDI-II is a well-established measure of the intensity of 
depressive symptoms, with high test-retest reliability, internal consistency and agreement 
with other depression scales (Beck, Steer, & Brown, 1996). 
A comprehensive review of the BDI-II (Wang & Gorenstein, 2013) used in various 
clinical and non-clinical samples found it had high internal consistency (average α = .90; 
range = .83-.96; Beck, Steer, Ball, & Ranieri, 1996), superior to the previous versions of the 
scale (BDI: Beck, Ward, Mendelson, Mock, & Erbaugh, 1961, BDI-A: Beck & Steer, 1993). 
 It also has good to excellent one-week test-retest reliability, between r = 0.73 and 0.96 
(Beck, Steer & Brown, 1996). There is good convergent validity with other major depression 
scales (r = 0.66-0.86) but also significant overlap with anxiety scales (r = 0.37-0.83), 
although this is likely due to overlapping symptoms, as well as high comorbidity rates 
between anxiety and depression (Wang & Gorenstein, 2013)  
Procedure 
Pre-treatment assessment. Before beginning treatment, participants attended a two-
hour individual session with a clinician, in order to collect information about the history and 
details of their OCD, gather baseline psychometrics and demographic information. This 
session was also used to establish individualised goals for each participant to work towards 
during treatment, based on their particular symptoms. An overview of the OCD model was 
presented and participants’ ability to comprehend the concept of appraisals and 
metacognitions was assessed; this being a vital prerequisite for them to be able to adequately 
engage with the treatment. Participants were also advised to remain on their prescribed 
medication throughout the treatment, keeping it stable whenever possible or noting any 
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changes in their weekly diary. They were also encouraged to compare their treatment 
progress against themselves at baseline, not to the other members of the group.  
Treatment sessions. Treatment consisted of nine, weekly, 4-hour group MCT sessions; 
followed by three, monthly, 1-hour follow-up maintenance sessions. Treatment followed the 
manual OCD Group Treatment: Facilitator’s Guidelines (Woolcock, 2011, unpublished 
manuscript). This manual for the treatment protocol was informed by rationale and structure 
of treatment in Wells (2009), Rees (2009) and Clark (2004) and followed a specific structure: 
Session 1: Psychoeducation, normalisation and motivation 
Session 2: Connections between thoughts, emotions and behaviour: Introduction to 
metacognitions 
Session 3: Detached Mindfulness, Attentional Training and Control of Thoughts  
Session 4: Behavioural Experiments; Thought Postponement  
Session 5: Halfway point ‘check in’: Review of material and practice of strategies 
learned to date 
Session 6: Exploring OCD metacognitions; Intolerance of Anxiety, Perfectionism 
Session 7: Over-estimated Threat; Thought-Action Fusion 
Session 8: Inflated Responsibility; Over-Importance of Thoughts 
Session 9: Blueprint & future planning, Relapse Prevention 
Treatment sessions were comprised of guided learning, goal-setting, discussion and 
relevant activities to learn and practice key skills, including behavioural experiments. The 
treatment manual sets out clear themes, messages, and tasks for each session, as well as the 
best ways to deliver the information. This includes the use of helpful metaphors to 
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demonstrate concepts, and the use of Socratic dialogue to engage the participants in the 
treatment. 
At the start of each session, participants completed the self-report psychometrics. A basic 
appraisal model of OCD (Clark, 2004; see Figure 1) was then drawn on the board to help 
participants keep the OCD process in mind, and assist them in identifying underlying 
appraisals. This is key, as clients often struggle with the identification of important 
appraisals, because they are distracted by the content of their intrusions (Whittal & McLean, 
1999). Key messages were reiterated throughout the treatment, to consolidate the concepts 
and facilitate understanding. One of these key messages is that intrusive thoughts are a part of 
life, and that the goal of the treatment is not to eradicate them but to change the relationship 
with them. 
Worksheets with summaries of key messages, examples and techniques were handed out 
for participants to use, and take notes on. For example, participants were given a sheet with 
common unhelpful metacognitions (such as “because I had this thought, it must be true”) as 
well as some helpful metacognitions to replace them with (such as “thoughts are not facts”), 
with space for them to add their own unhelpful and new helpful metacognitions to the list as 
they identified them. There were also worksheets for each session theme (such as “thought-
action fusion” or “over-importance of thoughts”) which included definitions, examples, 
summaries of experiments completed during class to challenge these appraisals (including the 
rationale behind the experiment), with space for participants to note down what they learnt 
from these experiments during the group brainstorm at the end of each session. 
Homework was given after each session, with the instruction that the skills learned in 
sessions were to be practiced and implemented by participants outside of the group setting. 
The importance of completing homework was highlighted, as a key part of strengthening 
skills and learning to self-direct their improvement. The homework included a diary template 
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for participants to record their obsessions and compulsions during the week, what triggered 
them, as well as their thoughts and feelings about them. After the introduction to the concept 
of metacognitions in session, the diary included space for participants to note down 
metacognitive beliefs and meanings associated with their obsessions and/or compulsions. 
Other tasks completed for homework were practicing the techniques of DM, ATT (using a 
CD), completing additional behavioural experiments and metacognitive thought records, as 
well as surveys, for example asking people they know about non-OCD experiences of 
intrusions. 
At the end of each session, there was a summary brainstorm guided by the clinician, with 
participants discussing and taking notes on the main points of that session. The following 
session would begin with a recap of the previous week’s main points, clarification of any 
concepts not understood by participants, and a review of the homework completed since the 
previous session.  
The final weekly session (session 9) consisted of creating ‘blueprints’ of participants’ 
OCD, including what triggered it, the metacognitions that maintained it, and alternative 
‘helpful’ metacognitions. It also included a discussion of helpful behavioural experiments, 
and what they learnt from completing them during treatment and in their own environments, 
and how they can continue to build on this learning. Finally, a relapse-prevention framework 
was utilised, helping participants realise the potential triggers of setbacks, recognise the signs 
of increasing anxiety, and practical strategies of how to deal with setbacks if they occur.    
Follow-up maintenance sessions. The three monthly follow-up maintenance sessions 
were designed to review how participants were managing to utilise the skills they learned 
during treatment; to help to deal with any challenges participants may have been facing; and 
to anticipate future difficulties, using a relapse prevention framework. Participants also 
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completed psychometric assessments at each follow-up session. The last maintenance session 
also included a final review of participants’ individual goals.  
Therapists: Training and Experience  
Over the duration of the study, three clinical psychologists and one specialist trained 
nurse delivered the treatment groups in pairs. Clinician experience in treating anxiety 
disorders ranged from 3 to 25 years. All of the therapists had prior training and experience in 
delivering CBT, as well as experience in conducting group CBT for anxiety disorders, and 
individual treatment of OCD. Therapists received MCT education from a supervisor and an 
experienced clinical psychologist colleague, who had both attended MCT workshops by 
Adrian Wells. All of the therapists were well-versed in key CBT and MCT constructs, also 
working from the detailed treatment manual (Woolcock, 2011), which included a breakdown 
of each session into key components, so that the groups were run in a consistent manner. 
Data Analyses 
Data were analysed using IBM SPSS Statistics (Version 22.0) for Windows. 
Baseline data from all five groups was compared to see whether there were any 
differences which would prevent the data being analysed together. A one-way ANOVA 
detected no significant differences between groups in age, severity of OCD symptoms (Y-
BOCS and PI-WSUR) or severity of depressive symptoms at baseline. The data was thus 
analysed as one group to increase power.  
The data was checked to ensure it met the normality assumptions of a paired-sample t-
test; which was confirmed statistically through inspection of skew and kurtosis scores as well 
as checking standardised difference scores for any outliers. The data was deemed to meet the 
assumption of normality, and no other assumptions about the data were violated. 
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Repeated-measures t-tests were used to analyse the differences between pre, post and 
follow-up scores for the outcome measures. Effect sizes were calculated using a calculator 
derived from Morris and DeShon’s (2002) method for calculating the effect sizes of repeated-
measures data, which takes into account and corrects for the correlations inherent in data 
drawn from dependent samples. This allows the effect sizes to be compared with effect sizes 
from between-subject designs. 
A regression analysis was also completed to see which baseline factors predicted Y-
BOCS follow-up scores, using common variables known to influence treatment response:  
gender, OCD chronicity, level of depression at baseline, OCD severity at baseline and 
comorbidity. However, this analysis yielded no significant results. 
Bivariate correlations were then carried out to investigate the relationship between 
metacognitive beliefs and key symptom variables at baseline and follow-up. This was 
completed using means, and change scores (the mean difference between baseline and 
follow-up).  
Finally, an independent samples t-test was conducted to compare the Y-BOCS results of 
the current group MCT for OCD with the results of Rees and van Koesveld (2008).  
 Missing data. There was a small amount of missing data from the study. Where this 
occurred for main outcome measures (Y-BOCS, PI-WSUR or BDI-II) which were measured 
at each session, a ‘last observation carried forward’ (LOCF) method was utilised. The 
majority of the missing data points were from the final follow-up session (session 12). In this 
case, data from another follow-up session (session 10 or 11) were carried forward to use as a 
‘follow-up’ measure. If anything, the LOCF yields a conservative estimate of the true figure, 
especially given the trend for our sample was to continue to experience symptom 
improvement between post-treatment and the final follow-up session. In total, 6.5% of the 
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data was carried forward in this manner. Key outcome data were collected at each session, 
which allows confidence in the LOCF method, as the ‘last observation’ was generally carried 
forward only one session. For other measures (i.e. the OCD-S) which were unfortunately not 
completed at every session for all participants, instances of missing data were unable to be 
carried forward, and the participant was excluded for that particular analysis. This was the 
case for only two participants (9.1%). For one participant, baseline measures were 
incomplete; therefore data collected before the participant’s first treatment session (session 2) 
was used as pre-treatment data. 
Clinical significance. In the current study, the use of the ‘Reliable Change Index’ (RCI; 
Jacobson & Truax, 1991) as a measure of clinically-significant change and “recovery” was 
considered, in addition to statistical significance. However, despite the standardised nature of 
the method, as well as its extensive use in other fields of research, the RCI has been 
inconsistently applied in the OCD literature. The reason for the inconsistencies in applying 
the RCI is that the criteria and cut-off figures change based on which data is used to provide 
normative data. Its use is also limited by the lack of normative data from non-clinical 
populations for OCD. 
Two scores on the Y-BOCS are required to apply the RCI method of significance: firstly 
a pre-post change score, which designates the magnitude of symptomatic improvement 
required to reach “clinically significant” change; secondly a cut-off point, below which post-
treatment scores are deemed to indicate “recovery” (Fisher & Wells, 2005b). A small 
selection of studies utilising RCI criteria for OCD (using the Y-BOCS) demonstrates the 
discrepancies in its application:  
“Reliable change” scores: 5 (van Oppen et al., 2010), 6 (Whittal, Thordarson, & 
McLean, 2005), 7 (Simpson et al., 2013), 10 (Fisher & Wells, 2005b; Rees & van 
Koesveld, 2008). 
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Cut-off “recovery” scores: 12 (Whittal et al., 2005), 14 (Simpson et al., 2013; Fisher & 
Wells, 2005b; Rees & van Koesveld, 2008), 16 (van Oppen et al., 2010). 
Ultimately, the decision was made to not include the RCI as an additional measure of 
significance in the current study, as its inconsistent application in the literature makes the 
designation of “reliable change” and “recovery” unable to be compared across studies, and 
therefore limits the utility of this method. Furthermore, the current study utilised the self-
report version of the Y-BOCS, which Fisher & Wells (2005b) deemed an exclusion criteria 
for their calculations of the RCI for the Y-BOCS – as the validity of the use of the self-report 
version of the scale for RCI calculations is unknown.  
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Results 
Demographics  
Table 1 contains the demographics of the treatment completers. The sample consisted 
of eight males and 14 females, with ages ranging between 18 and 64 (M=30.8, SD = 12.6 
years). The majority of participants identified as New Zealand European (81.8%), although 
other ethnicities represented were Maori, Australian European, American New Zealander and 
Afghan/Indian (all 4.5%; one participant each). There were seven students, seven part/full-
time workers, five who were unemployed, one retiree and two who declined to answer. Six 
participants (27.3%) were receiving a sickness benefit from the government. The education 
level of the sample ranged from 1-4 years of high school (27.3%), 5-6 years of high school 
(31.8%), trade/technical certificate (4.5%), Bachelor degree or diploma (22.7%) and a 
postgraduate degree (13.6%). The majority of the sample (59.1%) reported their relationship 
status as ‘single’, with a smaller proportion married or in a committed relationship (27.3%). 
The average age of onset of OCD symptoms, as recalled by the participants, was 19.8 
years (range 5-44 years), with over half of the participants reporting symptoms since 
childhood (22.7%) or adolescence (31.8%), the rest (40.9%) reporting onset in adulthood. 
There was a lot of variation in the chronicity of OCD, with the mean length of the disorder 
being 11.0 years (range 0.5-47 years). Many participants (63.6%) were experiencing current 
psychological comorbidity, which increased to 77% when taking into account lifetime 
comorbidity. Of those with current comorbidity, 78.6% had at least one comorbid anxiety 
disorder, and 50% had at least one mood disorder. Around two thirds (63.6%) of the 
participants were taking psychotropic medication during the treatment; all of whom were 
taking some form of anti-depressant. Over a third (35.7%) of those on psychotropic 
medication were taking anti-psychotics (prescribed at low doses for anxiolytic purposes) and 
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Table 1  
Completers’ Demographics and Baseline Characteristics 
Variable N (%) or M (SD) 
N 
Gender 
Female 
Male 
Age, years (SD)  
Range 
Ethnicity 
NZ European 
Maori 
Other 
Occupation 
Full/Part-time student 
Full/Part-time worker 
Retired/not working by choice 
Unemployed 
Other  
Sickness Benefit 
Education 
1-4 years of high school 
5-6 years of high school 
Trade/Technical certificate 
Bachelor degree/Diploma 
Postgraduate degree 
Relationship Status 
Single 
Married/committed relationship 
Other 
Current comorbidity 
Anxiety Disorder 
Mood Disorder 
OCD Onset (mean age, years (SD)) 
Childhood (<13 years) 
Adolescence (13-18 years) 
Adulthood (>18) 
Chronicity (years (SD)) 
Taking Psychotropic Medication 
22 
 
14    (63.6%) 
8      (36.3%) 
30.8 (12.6) 
18-64  
 
18    (81.8%) 
1      (4.5%) 
3      (13.6%) 
 
7      (31.8%) 
7      (31.8%) 
1      (4.5%) 
5      (22.7%) 
2      (9.1%) 
6      (27.3%) 
 
5      (22.7%) 
7      (31.8%) 
1      (4.5%) 
5      (22.7%) 
3      (13.6%) 
 
13    (59.1%) 
6      (27.3%) 
3      (13.6%) 
14    (63.6%) 
12    (54.5%)                       
9      (40.9%)                       
19.8 (10.16) 
5      (22.7%) 
7      (31.8%) 
9      (40.9%) 
11.0 (12.1) 
14    (63.6%) 
Note. Incomplete demographics information for one participant. 
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14.2% were taking anti-anxiety medication. Pre-treatment scores (Table 2) show that the 
sample had OCD symptoms in the “moderate” severity category (based on Y-BOCS total 
score) and fell just below the “moderate” cut-off for depression, putting the sample at the 
high end of “mild” depressive symptoms. The sample fell slightly below average severity of 
clinical OCD samples for the Y-BOCS (20.6 vs 21.9) and the PI-WSUR (52.0 vs 54.9; 
Antony, 2001). Attendance rates were good, with 40 percent attending all 12 sessions (9 
treatment sessions and 3 follow-up sessions), and the majority of those missing sessions only 
missing one. Average attendance for all participants was 10.8 (of 12) sessions (89.8%).  
Completers vs. Non-completers 
At pre-treatment, there were no significant differences between completers (N=22) and 
non-completers (N=4) in age, education or baseline depression. Non-completers had 
significantly higher OCD symptom scores at baseline than completers, as measured by both 
the Y-BOCS (Non-completers: M=29.0, SD=8.4; Completers: M=20.8, SD=4.0; t(24)= 3.17, 
p=.004) and PI-WSUR (Non-completers: M=75.8, SD=32.1; Completers: M=49.8, SD=20.6; 
t(24)= 2.13, p=.04). The mean for non-completers was over two standard deviations higher in 
Y-BOCS total score than the mean for completers. This difference at baseline is such that 
those who did not complete the group treatment programme were in the “severe” category, 
whilst those who completed the treatment were in the “moderate” severity category (based on 
Y-BOCS total scores).  
Outcome Measures 
Table 2 presents the means, standard deviations and change scores for the key obsessive-
compulsive and depression measures at pre-treatment, post-treatment and follow-up. 
Subscale data for the Y-BOCS, PI-WSUR and OCD-S subscales are presented in Table 3.  
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Table 2 
Mean Y-BOCS, PI-WSUR and BDI Scores at Pre-Treatment, Post-Treatment and Follow-Up 
  M (SD)  Change 
    Pre - post  Pre - Follow-up 
Measure  Pre Post Follow-up  t d %  t d % 
Y-BOCS  20.6 (3.7) 16.3 (5.2) 14.5 (5.8)  4.18** 0.9 20.7  5.64** 1.3 29.8 
PI-WSUR  52.0 (21.2) 34.5 (20.6) 30.2 (21.0)  4.97** 1.1 33.7  6.37** 1.4 41.9 
BDI-II  19.4 (10.2) 14.6 (12.0) 13.3 (11.0)  3.58* 0.8 24.4  4.26** 0.9 31.5 
Note. * significant at p<.01; ** significant at p<.001. ‘Y-BOCS’= Yale-Brown Obsessive Compulsive Scale. 
‘PI-WSUR’ = Padua Inventory–Washington State University Revision. ‘BDI-II’ = Beck Depression Inventory II 
Obsessive-compulsive symptoms. Following the hypotheses, there was a significant 
decrease in total Y-BOCS score from pre-treatment to post-treatment, which was further 
improved at follow-up.  The effect size for the pre–post (d=0.9) and pre–follow-up (d=1.3) 
improvements were both very large. The average Y-BOCS score for the sample at follow-up 
puts the group in the “mild” symptom severity category, which decreased from the 
“moderate” category at baseline. By follow-up, no clients remained in the ‘severe’ symptom 
category. Each of the Y-BOCS subscales also showed significant improvement from pre-
treatment to follow-up, with symptom reductions of both rituals (d=0.9) and obsessions 
(d=1.0) reaching large effect sizes.  
There was also a significant decrease in total PI-WSUR score from pre-treatment to post-
treatment, which was further reduced at follow-up. Large effect sizes were found at both 
post-treatment and follow-up. Four of the five subscales demonstrated significant decreases, 
with obsessional thoughts to harm self/others, contamination obsessions and washing 
compulsions, checking compulsions and dressing/grooming compulsions all improving 
significantly between pre-treatment and follow-up, with large effect sizes (d=0.9-1.2). The 
largest decrease was observed in the dressing/grooming compulsions subscale, with reported 
symptoms in this category being reduced by more than half from pre-treatment to follow-up.  
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Table 3 
Subscale Means at Pre-Treatment and Follow-Up  
Measure   M (SD)  Change 
  Pre Follow-up  t d % 
Y-BOCS 
  Rituals 
  Obsessions 
  
9.5     (3.8) 
11.1   (2.0) 
 
6.6     (3.91) 
7.8     (3.19) 
  
3.98** 
4.45** 
 
0.9 
1.0 
 
30.1 
29.5 
PI-WSUR 
  Thoughts of harm to self/others 
  Impulses to harm self/others 
  Contamination obsessions/ washing 
  Checking compulsions 
  Dressing/grooming compulsions 
  
10.3   (5.9) 
4.0     (4.8) 
14.0   (10.7) 
19.5   (10.3) 
4.3     (4.2) 
 
5.2     (4.0) 
3.3     (4.1) 
9.1     (7.6) 
10.7   (9.8) 
2.0     (2.5) 
  
4.54** 
   0.88 (ns) 
3.73** 
5.58** 
3.71** 
 
1.0 
0.2 
0.9 
1.2 
0.9 
 
27.5 
17.0 
35.1 
45.1 
53.7 
OCD-S  
  Distress 
  Coping Behaviours 
  Avoidance Behaviours   
  Beliefs 
  
4.8     (1.2) 
18.0   (7.6) 
38.8   (12.5) 
476.6 (173.9) 
 
3.7     (1.8) 
11.1   (8.1) 
23.1   (15.6) 
243.3 (184.9) 
  
2.93* 
5.52** 
6.63** 
6.40** 
 
0.7 
1.2 
1.5 
1.4 
 
24.0 
38.2 
40.4 
49.0 
Note. * significant at p<.01; ** significant at p<.001; ‘ns’ = non-significant. ‘Y-BOCS’= Yale-Brown Obsessive 
Compulsive Scale. ‘PI-WSUR’ = Padua Inventory – Washington State University Revision. ‘OCD-S’ = 
Obsessive Compulsive Disorder Scale. 
 
No significant pre-follow up change was found for the obsessional impulses to harm 
self/others subscale, although this subscale was already low at baseline.   
Similarly, there was significant reduction in scores for each of the four OCD-S items, 
with demonstrable improvement in scores for distress, coping behaviours, avoidance and 
beliefs. The reduction in distress reached a medium effect size, with the other three subscales 
demonstrating large effect sizes. Notably, the scores for the beliefs subscale decreased by 
almost half between the beginning and end of the treatment programme.  
Depressive symptoms. As predicted in the hypotheses, the sample also experienced 
decreases in depressive symptoms, with BDI-II scores decreasing significantly from pre-
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treatment to the end of treatment. This decrease was maintained at follow-up. Large effect 
sizes were found between pre-treatment and post-treatment (d=0.8) as well as follow-up 
(d=0.9). At follow-up, the mean BDI-II score puts the sample in the “minimal” depression 
category, the lowest severity designation.  
Metacognitive beliefs. Also consistent with the hypotheses, a large correlation was 
found between OCD severity (Y-BOCS) and metacognitive beliefs (OCD-S ‘Beliefs’ 
subscale) at both baseline (r=.61, p= .003, N=22) and at follow-up (r=.70, p=.001, N=20). 
Similar results were attained with the PI-WSUR total score, with a significant correlation 
with metacognitive beliefs at follow-up (r=.56, p=.01, N=20) although not at baseline. These 
findings from two separate OCD measures suggest that faulty metacognitive beliefs are 
strongly associated with OCD severity, with higher endorsement of metacognitive beliefs 
being associated with higher Y-BOCS score. In addition, utilising change scores between 
baseline and follow-up, the correlation between Y-BOCS and metacognitive beliefs indicated 
that a reduction in faulty metacognitive beliefs was significantly associated with symptom 
improvement during the treatment period (r=.58, p=.007, N=20). There was also a moderate 
correlation between metacognitive beliefs and BDI-II at follow-up (r=.46, p=.04, N=20).  
Taken together, these findings suggest that those with higher faulty metacognitive OCD 
beliefs at follow-up also experience higher severity of OCD and depressive symptoms. 
However, the conclusions able to be drawn from this finding, although significant, are limited 
by the lack of validation data for the OCD-S. 
Comparison with Rees & van Koesveld (2008). Table 4 presents a comparison 
between the current study and Rees and van Koesveld’s (2008) study. Rees & van Koesveld’s 
(2008) sample had a slightly higher baseline severity than the current study, although this 
difference did not reach significance (p=.10). There were no significant differences between  
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Table 4 
Comparison between Current Study and Rees & van Koesveld (2008) 
 Rees & van Koesveld (2008) Current Study 
N 8 22 
Referrals Consecutive Consecutive 
Setting Outpatient Outpatient 
Dropouts 0 5 (18.5%) 
Group size 8 2-6 
Treatment sessions 12  9 
Follow-up sessions 1 (3 months) 3 (monthly, for 3 months) 
Treatment session length  2 hours 4 hours 
Psychotropic medication use 1 (12.5%) 14 (63.7%) 
Baseline depression † 19.2 19.4 
OCD chronicity 3-28 years 0.5-47 years 
OCD severity (Y-BOCS)* Pre: 
                                          Post: 
                                Follow-up: 
23.2 (SD=3.9)    [moderate] 
14.1 (SD=6.2)    [mild] 
9.0 (SD=6.1)      [mild] 
20.6 (SD=3.7)     [moderate] 
16.3 (SD=5.2)     [moderate] 
14.5 (SD=5.8)     [mild] 
Y-BOCS change: Pre – Post: M 
                                                t 
                                               d, % 
                Pre – Follow-up:    M 
                                               t 
                                               d, % 
9.1 
4.5, p=.00 
1.8**, 39.2% 
14.2 
6.5, p=.00 
2.4, 61.4% 
4.3 
4.2, p=.00  
0.9, 20.7% 
6.1 
5.6, p=.00 
1.3, 29.8% 
†Note – Rees & van Koesveld (2008) utilised the original BDI (Beck et al., 1961) in their study, the current 
study utilised the updated version, the BDI-II (Beck et al., 1996). There is no conversion information 
between these two particular versions of the scale, therefore, scores may not be directly comparable. 
*Note – Y-BOCS was clinician administered in the Rees & van Koesveld (2008) study, and was self-
reported in the current study. 
**Note – in their paper, Rees & van Koesveld (2008) used a method of obtaining an effect size that did not 
use the pooled standard deviation (and assumes equal standard deviation for the two samples, which was 
not the case). The effect size here has been updated using the same method of calculation as the current 
study, to allow for direct comparison. This yielded lower effect size estimates than reported by Rees and 
van Koesveld (2008) in their research paper. 
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the groups immediately post-treatment (p=.34), although there was a significant difference 
between the follow-up results of the two studies. At follow up, Rees and van Koesveld’s 
(2008) sample demonstrated significantly higher improvement than the current sample 
(t(1,28)=2.24, p=.03), with a mean difference between the studies at follow-up of 5.5 points 
on the Y-BOCS (95% CI [0.47-10.44]). Between baseline and follow-up, participants in the 
current study improved by 29.8%, compared to 61.4% in the Rees & van Koesveld study. 
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Discussion 
Previous research has provided preliminary support for the role of metacognitions in the 
aetiology and maintenance of OCD. Most of these studies test certain aspects of the 
metacognitive approach, however there are very few studies which apply MCT to the 
treatment of OCD (Fisher & Wells, 2008; Rees & van Koesveld, 2008; Shareh et al., 2010). 
In response to the growing empirical evidence for MCT in OCD and a number of different 
disorders (see Wells, 2009 for a review), and the success of Rees & van Koesveld (2008), the 
current study aimed to test the efficacy of MCT of OCD in a group setting, only the second 
time this has been attempted. It also aimed to extend the field by investigating the 
relationship between metacognitive beliefs and OCD symptoms in a naturalistic, clinical 
setting. 
These aims were achieved by recruiting five groups of participants, through consecutive 
referrals, to participate in a new MCT treatment for OCD (Woolcock, 2011). Through a 
combination of semi-structured interview (baseline assessment only) and self-report 
measures, participants’ levels of OCD symptoms, depressive symptoms and faulty 
metacognitive beliefs were gathered at baseline, at the end of the 9-session treatment 
programme, and at a 3-month follow up period.  
Summary of Findings 
It was predicted that at post-treatment and follow-up, OCD symptom severity would be 
significantly improved compared to baseline severity. This was borne out in the results, with 
significant reductions in both Y-BOCS and PI-WSUR scores. The reduction in Y-BOCS 
scores was large for both post-treatment and follow-up, with an improvement of just under 
30% by the 3-month follow up period. The mean severity score decreased from the 
“moderate” symptom category to “mild” by follow-up. This pattern of results was the found 
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for both obsessions (29%) and compulsive rituals (30%), both reducing significantly by 
follow-up. 
The improvement in OCD severity was supported by the PI-WSUR results, in which 
OCD symptoms decreased by just under 42% by follow-up, denoting a large effect size. This 
result was comprised of significant improvement in four of five subscales: ‘obsessional 
thoughts to harm self/others’ (28%); ‘contamination obsessions and washing compulsions’ 
(35%); ‘checking compulsions’ (45%) and ‘dressing and grooming compulsions’ (54%). The 
‘obsessional impulses to harm self/others’ subscale experienced a 17% decrease, but did not 
reach significance. However it is likely that this is due to a ‘floor’ effect – this particular 
subscale has a possible range of 0-32, with the sample having a low baseline mean of only 4; 
indicating this sample did not experience these particular impulses to a high degree to start 
with. 
As expected, there was also a significant decrease in depressive symptoms by the post-
treatment (24%) and follow-up time points (31%). The improvement in depressive symptoms 
reached a large effect size, and signified a shift from the high end of “mild” (on the border of 
“moderate”) to the low end of mild (on the border of “minimal”).  
Also in line with predictions was the significant decrease in faulty metacognitive beliefs, 
as measured by the OCD-S. By the 3-month follow up, the extent of endorsement of these 
beliefs had almost halved (49%) compared to baseline. The predicted relationship between 
metacognitive beliefs and OCD symptoms also emerged: Y-BOCS total and OCD-S beliefs 
were significantly correlated at baseline, as well at follow-up, so that those participants 
endorsing more faulty metacognitive beliefs (such as “some thoughts must always be 
controlled”) also had higher OCD severity. Furthermore, the change scores in these two 
measures were also significantly correlated: a larger reduction in metacognitive beliefs from 
baseline to follow-up was significantly related to larger reductions in OCD severity (as 
45 
 
measured by the Y-BOCS). In addition, a significant, positive relationship between 
depressive symptoms and metacognitive beliefs at follow-up was also found. 
In addition to these hypothesised effects, possible predictors of outcome were explored 
in a regression analysis. The factors, which are commonly implicated as predictors of 
treatment outcome (APA, 2007), were gender, OCD chronicity, level of depression at 
baseline, OCD severity at baseline, comorbidity. However, surprisingly none of these 
baseline factors emerged in the current study as significant predictors of OCD severity at 
post-treatment or follow-up.  
A comparison between the primary results of the Rees and van Koesveld (2008) group 
treatment, and the current study was also undertaken. This revealed that the current study had 
a slightly lower baseline Y-BOCS than the Rees and van Koesveld (2008) sample (although 
this was not statistically significant), and also yielded significantly less Y-BOCS 
improvement at follow-up than their sample. Possible reasons for this finding will be 
discussed below. It is important to note that despite these differences, clinically both groups 
fell into the ‘moderate’ severity category at baseline, and the ‘mild’ category at follow-up, 
which puts the statistically significantly different results into perspective.  
An initial t-test also revealed that although those who completed the treatment, and those 
who dropped out did not differ significantly on demographic information or baseline 
depression, non-completers had significantly higher OCD symptoms at baseline (Y-BOCS 
and PI-WSUR), which put them in the “severe” symptom category, compared to the 
“moderate” symptom category of the completers. This is a limitation of the current study, 
which will be discussed below. 
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Interpretations and Implications of Current Research 
The principal implication of the current study is the demonstration that group 
metacognitive therapy is an effective treatment for OCD, which replicates the findings of the 
only other study of this kind in the literature (Rees & van Koesveld, 2008). This lends weight 
to the conclusions that MCT for OCD is both effective, and able to be successfully delivered 
in a group setting. The efficacy of group MCT for OCD has now been successfully 
demonstrated in outpatient settings in two locations, with different cohorts, treatment 
manuals, and therapists. The current study also represents a different metacognitive approach 
than the Rees & van Koesveld (2008) study; building on the current field. These promising 
preliminary findings justify further replication and research to lend further support to the 
efficacy of group MCT for OCD, suggestions for which will be discussed below. 
A comparison with the existing literature on OCD group treatments (CBT and ERP) 
shows that the current study’s treatment effect sizes are favourable. Jónsson and Hougaard’s 
(2009) meta-analysis of group OCD treatment found a pre-post Y-BOCS ES range of 0.78 to 
1.89, with a mean of 1.18. The pre-post ES for the Y-BOCS in the current study was 0.92, 
and further improvement over the three month follow-up period gave a pre–follow-up ES of 
1.29. Given the application of MCT to OCD is only in the preliminary stages, obtaining 
results comparable to well-established, recommended treatment modalities is encouraging. It 
is also encouraging that these results were found in a group treatment format, the implications 
being that not only is MCT effective, but it can also be delivered in a way that allows many 
people to benefit at the same time; maximising cost-effectiveness and the use of therapist 
time. The findings of this study also indicate that a metacognitive approach can be 
implemented effectively, independent of the developers of these therapies. 
The findings demonstrate that the treatment can effectively reduce both aspects of the 
disorder: obsessions and compulsions, with large pre-treatment to follow-up reductions in Y-
47 
 
BOCS scores for both of these subscales. This is supported by the PI-WSUR subscale results, 
showing reductions with large to very large effect sizes for obsession and compulsion-based 
subscales. It is also supported by the OCD-S subscales measuring coping behaviours and 
avoidance behaviours, although the conclusions to be drawn from this scale are limited given 
that psychometric and normative data are not available. This is an important preliminary 
finding for MCT, especially given that previous treatments were seen to be more effective for 
compulsions (behavioural therapies) or obsessions, but not both (Whittal, Woody, McLean, 
Rachman & Robichaud, 2010).  
Another promising result was the significant decrease in depressive symptoms. This is 
significant because it demonstrates that the treatment impact is not limited to OCD 
symptoms. This is consistent with the finding that depressive symptoms largely develop after 
OCD symptoms, arguably in response to the debilitating disorder (Clark, 2004). It is also 
consistent with a transdiagnostic perspective of underlying commonalities between many 
emotional disorders (e.g. Clark, 2009), particularly faulty metacognitive processing and 
appraisals, such as the CAS (e.g. Wells & Matthews, 1994).  
In light of the pattern of results, it is surprising that distress, measured by the OCD-S, 
had the smallest pre–follow-up change of all the significant results. However, it was still a 
statistically significant decrease, with reported distress levels dropping by just under a 
quarter, with a medium-large effect size. Possible explanations for this are that as an 
unvalidated scale, the OCD-S is not sensitive to change in distress over time, or that distress 
did not decrease as much as other symptoms, due to the fact that some symptoms still 
remained at the final time point – causing residual distress. Another possible explanation, 
discussed by the therapists during the treatments, is that as the treatment progressed, the 
participants were gaining increased insight about the impact of their OCD on their lives; 
which may have contributed to this finding.          
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Consistent with theories of metacognition in OCD, one of the largest pre–follow-up 
changes was the decreasing endorsement of metacognitive beliefs, as measured by the 
‘beliefs’ subscale of the OCD-S (Wells, 2009). This reduction, as well as the significant 
correlation between metacognitive belief change and OCD symptom change is consistent 
with the literature emphasising the role of maladaptive metacognitive beliefs in the 
persistence of OCD symptoms. This finding suggests that the focus on the modification of 
maladaptive cognitive beliefs in the treatment was successful, and influenced OCD 
symptoms.  
However, it is possible that the drop in metacognitive beliefs was simply a co-effect of 
the drop in OCD symptoms, rather than having a causal role. Given the design of this study, it 
is not possible to test this alternate explanation. However the weight of research presented in 
support of the role of metacognition in the disorder suggests that faulty metacognitive beliefs 
are implicated in both the aetiology and the maintenance of OCD symptoms (e.g. Fisher & 
Wells, 2005a; Myers, Fisher & Wells, 2009). Given that modification of metacognitions was 
a central facet of the treatment programme, the large decreases in metacognitive beliefs in the 
current study suggests a specific treatment effect which drove the improvement in OCD and 
depressive symptoms, rather than the other way around. However, confirming that 
metacognitive beliefs are the mechanism of therapeutic change is something that needs to be 
explored in future research, with an adequate comparison group. 
Given the current treatment demonstrated lower symptomatic improvement than the 
study on which it is based (Rees & van Koesveld, 2008), it is important to compare the two, 
and examine which factors in the current study could potentially account for this finding. It is 
possible that differences in the application of metacognitive approaches between the current 
study and Rees and van Koesveld (2008) play a role in the different treatment outcomes; 
representing “soft” and “hard” metacognitive approaches respectively. Rees & van Koesveld 
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followed Wells (2000) directly, implementing his prototype model for OCD, whereas the 
current study combined aspects of the metacognitive approach of Wells (2009) with elements 
of CBT from Clark (2004). It is not possible with the current data to investigate whether the 
blended approach taken in the current study contributed to the lower symptomatic 
improvement than observed in the Rees & van Koesveld (2008) study. Even if clinical and 
empirical experience has demonstrated the efficacy of certain treatment elements, it is not 
desirable to add these elements to a new treatment if they are not useful or necessary. 
Therefore it is something that is worth investigating in future research, so that the application 
of MCT remains evidence-driven. 
There were also several other differences between the two studies which may have 
played a role (see Table 4): the current sample had a much higher rate of psychotropic 
medication use (63.7% vs 12.5%); the current group programme only included 9 ‘treatment’ 
sessions, and then three monthly follow-up sessions, whereas Rees & van Koesveld (2008) 
had 12 weekly sessions with only one follow up; our treatment sessions were much longer (4 
hours, compared to 2 hours); as well as the possibility of socially-desirable responding in the 
Rees & van Koesveld (2008) study due to Y-BOCS interview being conducted by the same 
person leading the group. The current study utilised self-reporting, which may limit this bias; 
however this cannot be confirmed, as the clinician leading the group was still present in the 
room whilst psychometrics were completed. It is important to reiterate that, despite the 
significant difference at follow-up between Rees and van Koesveld (2008) and the current 
study, both group means were in the “mild” symptomatic category.  
A question posed by Myers and Wells (2013), in response to the increasing evidence 
for the role of metacognition in OCD, is whether different emphases and techniques of 
treatments aiming to modify metacognitions may have different outcomes. As an emerging 
theoretical and clinical field, there are still aspects that need discussing and refining at the 
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juncture of theory and practice. For example, whether “hard” MCT, or “soft” MCT, blended 
with elements of CBT is more effective in the treatment of OCD, or exactly which elements 
can be successfully combined. Wells (2005) speculates that the inclusion of certain cognitive 
techniques, such as thought records, may be counterproductive, in that noting down instances 
of obsessional intrusions is likely to increase monitoring and meta-awareness of intrusions; 
which is ultimately contraindicative. However, both the current study, and Rees & van 
Koesveld (2008) utilised metacognitive thought records, and both achieved significant 
reduction in symptoms. Similarly, both the current study, and Simons et al. (2006) combined 
treatment aspects of CBT and MCT and achieved significant improvement in symptoms. As 
the boundaries of MCT are still up for debate, as well as whether MCT represents a 
broadening of CBT, or a separate entity; this will be a question that comes up again as more 
theoretical and empirical literature is added to the field. 
Strengths and Limitations 
The use of a naturalistic clinical sample is a strength of the current research, with much 
OCD research being limited by the use of non-clinical samples (Grøtte et al., 2015). In 
addition, the participants were selected consecutively through contact with mental health 
services, meaning they are representative of the target audience of the treatment. The current 
sample, not excluded on the basis of psychological comorbidities or use of medication, is also 
a strength; and gives our findings more external validity than those with more strict exclusion 
criteria (such as Fisher & Wells, 2008; Shareh et al., 2010) who likely found more inflated 
results than would be found in a more representative sample. 
Another key strength of the current study, especially for application to practice, is that 
there was only an average of 13.6 contact hours per participant (which would be 10.5 hours if 
each group had six members). Compared to individual therapy, it therefore represents a very 
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time efficient, cost-effective way of delivering OCD treatment. In addition, the treatment 
programme was highly acceptable to clients, with feedback and session ratings on the themes 
‘relationship’ ‘goals and topics’ ‘approach or method’ and ‘overall’ being very high (average 
rating 90%).  
The current study also has several limitations. As an open trial, there was no control 
group against which to compare results. Without a control group, it cannot be ruled out that 
the significant symptomatic improvement is due to factors other than the treatment – for 
example the mere effect of seeking treatment, or natural course across time. However, a 
spontaneous symptomatic improvement of this magnitude would be unlikely, given the 
persistent, chronic nature of OCD. A comparable group study employing a wait-list control 
design found that OCD symptoms remained quite stable over a 3 month period (McLean et 
al., 2001). Similarly, the large reduction in metacognitive beliefs evidenced by the sample 
highly aligns with the content and goals of this particular treatment. This strongly suggests 
that the findings are a product of this specific treatment, however a follow-up study with a 
comparison group is necessary to confirm this.  
Another limitation is that apart from the initial assessment at baseline, all data were self-
reported. It is possible that this method of administration, especially within a group setting, 
with the clinician present, impacted the way that participants completed the various 
questionnaires (Bowling, 2005). However, other MCT trials (i.e. Rees & van Koesveld, 2008; 
Fisher & Wells, 2008) had limitations due to the clinician administering and scoring the 
measures being the same clinician running the treatment, which potentially also introduced 
biased responding. There is also evidence in the literature comparing self-reported and 
clinician-administered Y-BOCS scores, which found a slight discrepancy between the two; 
the clinician-rated score was slightly higher than the score self-reported by participants 
(Steketee et al., 1996). Also in regards to psychometrics, the use of the OCD-S, a new scale 
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which has yet to be validated, limits the conclusions that can be drawn from the findings from 
this particular scale.  
There was a dropout rate of 18.5%, which although is average for group treatments for 
OCD (Jónsson & Hougard, 2009), is still larger than desirable. The four participants who 
dropped out after the treatment started did so in the first few sessions, potentially representing 
a failure to engage. Those who completed treatment became engaged with the treatment in 
the early stages and remained committed to the treatment until the end. It is problematic that 
those who dropped out in the early stages of the study had significantly more severe 
symptoms at baseline than those who completed the treatment. This is a limitation firstly due 
to the non-random nature of these dropouts, but more importantly that individuals who 
probably needed the treatment might not receive it. However, the current study is not unique 
in having difficulty treating the more severe clients, with baseline severity being a well-
established predictor of poor treatment response (Farrell and Boschen, 2011). To mitigate the 
impact of stopping group treatment before it was finished, participants who dropped out were 
offered individual treatment instead.  
The current study only had a 3-month follow-up, which is another limitation (although is 
common in the literature). It would be prudent to include longer follow-up times in future 
research to get a better picture of patterns of symptoms and recovery over time. Another 
limitation is that the size of the groups in the study varied, due to patterns of recruitment and 
attrition. Due to attrition, one group was left with only 2 participants, compared to other 
groups with 4-6. It is possible that such a small group does not experience the same 
therapeutic benefits of group therapy (discussed earlier) as a larger group, and it is also 
possible such small groups would also feel the impact of dropouts more intensely. 
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Considerations for Future Research  
There are a few adjustments that future adaptations of this treatment protocol might 
observe in order to improve the conclusions that can be drawn from the findings. Firstly, a 
comparison group or waitlist-control design should be employed so that any results can be 
attributed to the treatment. Building on this, and addressing the identified gap in the current 
literature, it would be useful to include “soft” and “hard” MCT conditions, so that the 
effectiveness of delivering treatment based on these different approaches can be compared.  
Secondly, a better-validated measure of metacognitions (such as the MCQ-30) would 
allow for more confident conclusions about the relationship between metacognitive beliefs 
belief change and OCD symptom improvement. This would also make it more comparable to 
other studies investigating the role of metacognitions in the disorder. Future research would 
also benefit from including a measure of insight, as a potential predictor of treatment 
outcome. 
As is often the case in studies like this, a longer follow-up period would be optimal, and 
would be useful in future research. This would allow a look at how treatment effects are 
maintained in the long-term. Future studies should also utilise larger samples, so that 
statistical effects may be better detected (e.g. the non-significant result in the current study 
regarding predictors of outcome). 
Participants in this study were given weekly homework to complete between sessions 
(including keeping a diary, and practicing techniques and experiments learnt in the sessions). 
This homework is key to transferring concepts and techniques learnt in sessions into 
participants’ daily lives. Despite discussing the previous week’s homework at the beginning 
of each session, there was no measure of homework compliance utilised in the current study. 
Given the amount and importance of homework tasks assigned to the participants, future 
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studies would benefit from including a measure of homework completion or compliance. 
Studies measuring general homework completion (Whittal et al., 2005) and degree of 
adherence to ERP homework assignments (Simpson et al., 2011) have found that homework 
compliance significantly predicted treatment outcome, in that those with a high degree of 
homework compliance had lower Y-BOCS scores at the end of treatment. Simpson et al. 
(2011) used an adherence measure with excellent psychometric properties, and found that a 
one-point increase in adherence (range= 0-7) predicted a drop in Y-BOCS score of between 
4.3 and 6.5 points. Therefore the importance of encouraging and measuring homework 
compliance should not be underestimated.    
Another possibility in future studies would be to alter the session structure. According to 
the APA (2007) the length or number of sessions required to attain the best treatment 
outcome has not yet been established, but evidence suggests that between 13-20 weekly 
sessions is effective for most OCD patients (although this relates largely to CBT studies). It is 
common to have 12 treatment sessions in MCT (e.g. Wells, 2005; Rees & van Koesveld 
2008; Wells, 2013), whereas the current study only had 9 (followed by 3 follow-up sessions). 
Although each of our sessions was longer than these previous MCT studies (at 4 hours), there 
is the possibility with such demanding tasks and content, it would be better to spread the 
sessions out more, rather than to cover too much in one session. In fact, the sessions in the 
current study were substantially longer than the average length of a group therapy session for 
OCD in a meta-analysis (Jónsson & Hougaard, 2009), in which the majority fell at the 2-hour 
mark, with several at 1.5 hours, and only one study having sessions longer than 2 hours (2.5 
hours). Thus the number of sessions and their length would be something to consider before 
conducting further group treatments. 
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Conclusions  
As a therapy which is proving to be both effective and acceptable to clients (Wells, 
2013), MCT has the potential to address some of the limits identified in current OCD 
treatment, including the aversive nature of ERP, and a plateau in regards to efficacy. The 
current treatment demonstrated significant decreases in OCD symptoms, depressive 
symptoms and endorsement of faulty metacognitive beliefs between baseline and post-
treatment, as well as follow-up. With encouraging findings, high acceptability ratings, and 
excellent cost and time efficiency, the treatment would be a feasible clinical option for the 
treatment of OCD. 
Taken alongside the small handful of existing studies, the large treatment effect sizes 
found in the current study show that metacognitive therapy, delivered in a group format, is 
certainly effective, and is a very promising avenue for future research and practice. Questions 
remain as to whether delivering MCT alone, or alongside well-established CBT techniques, is 
the most effect method for treating OCD. Theoretical questions also remain about the 
positioning of MCT as a stand-alone therapy, or an update to the existing CBT field. There is 
now enough evidence of the viability of MCT for OCD to warrant a controlled, large-scale 
examination of MCT, which can elucidate the mechanisms of change, as well as the best 
approach to use in the delivery of MCT.  
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Appendix A 
 
 
ANXIETY DISORDERS UNIT   
PO Box 800, Christchurch 8140, New Zealand 
Telephone: (64) 03 364 0421 
Fax:  (64) 03 337 7822 
Office Hours: 8.30am – 5.00pm Monday – Friday 
 
Effectiveness, predictors of outcome, and mechanisms of change in Group Metacognitive 
Therapy for Obsessive Compulsive Disorder. 
 
Principal Investigator: Colette Mary Woolcock, Clinical Psychologist, Anxiety Disorders Unit 
 
Welcome to the Anxiety Disorders Unit 
Invitation To Participate In Study 
You are invited to take part in a study of the Group Metacognitive Therapy for Obsessive 
Compulsive Disorder (OCD) conducted by clinicians at the Anxiety Disorders Unit.  The aim 
of this study is to look at predictors of outcome (who this treatment works best for) and the 
pattern and process of therapeutic change. 
Metacognitive Therapy is a form for Cognitive Behaviour Therapy for OCD.  There has been 
some research in this area but we still have limited information about the predictors of 
outcome and the mechanisms of therapeutic change.  Most of the research has also been in 
overseas specialist research centres whereas this study involves clients of a specialist clinical 
service here in New Zealand. 
What The Study Involves 
We aim to collect data from our treatment groups over the next 5 years.  We would 
anticipate recruiting up to 6 patients per group and running 4 groups per year, giving a total 
of 120 patients over the 5 year period.  We would evaluate outcomes using self report 
questionnaires before, during, and after treatment (immediately following the completion 
of the group, then 1 and 3 months post group). 
Benefits And Risks 
This study aims to evaluate and potentially improve the treatment delivered at the Anxiety 
Disorders Unit.  The things we are looking at will hopefully enable us to identify who 
benefits most from this treatment and which would be of benefit for clients of Anxiety 
Disorders Unit as well as the delivery of the service. 
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We do not anticipate any physical risks involved with participation in this study.  Regarding 
the psychological effects, the effects of completing the questionnaires are not anticipated to 
be harmful.  If any issues were to be raised these would be addressed in the course of 
therapy. 
General 
The study involves Group Metacognitive Therapy.  At the end of the treatment your clinical 
needs will be discussed with you as part of your routine clinical care. 
Results 
This study is being conducted over 5 years from 2012.  We would anticipate that the results 
will be used to educate and inform professionals and the public about anxiety disorders and 
their treatment.  This information will be in the form of publication in journals and 
presentations. 
Confidentiality 
We will use the results collected in this research to educate professionals and the public 
about anxiety disorders.  No material that could identify you will be used in any reports.  
Your individual data remains confidential to the Anxiety Disorders Unit.   
Ethical Approval 
This study has received ethical approval from the Upper South Regional Ethics Committee.  
Ethic reference number: URA/12/EXP/010 
Please feel free to contact Colette Woolcock (telephone contact 364 0421 or by letter to 
Anxiety Disorders Unit, P.O. Box 800, Christchurch 8140) if you have any questions about 
this study. 
If you would like any feedback from your questions, or if you have any difficulties, please ask 
your co-ordinator to go over them with you.  If you are in any way concerned about being 
asked to complete these questions, please discuss this initially with a team member.  You 
may wish to talk with someone not directly involved with your care.  These include: 
 
Unit Manager, Anxiety Disorders Unit, P.O. Box 800, Christchurch 8140 
Phone: (03) 364 0421 or Fax: (03) 337 7822 
 
An Independent Health & Disability Advocate 
Free Phone: 0800 555 050 
Free Fax: 0800 2SUPPORT (0800 2787 7678)  
If you wish to talk with a Pukenga Atawhai (Maori mental health worker) please contact 
your case manager to arrange this. 
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Appendix B 
Effectiveness, predictors of outcome, and mechanisms of change in Group Metacognitive 
Therapy for Obsessive Compulsive Disorder. 
 
 
Consent Form 
 
I, _________________________________________________________ (print full name)
  
 
of _________________________________________________________ (address) 
 
 _________________________________________________________ (phone) 
 
understand the reasons for this evaluation, as outlined above, understand participation is 
voluntary and that if I do not complete these questionnaires it will not affect my treatment 
from this service in any way.  Similarly, I can withdraw from this information gathering 
process at any time, for any reason, without adversely affecting my present treatment, or 
any future treatment. I understand that my questionnaires will be kept in a locked cabinet 
and that data used from these questionnaires will not be identifiable in any way. 
 
Signed: ____________________________________________  Date: ____________ 
 
Clinician/Witness ____________________________________________________________ 
